CVS Health Launches Company To Produce Cheaper ‘Biosimilar’ Versions Of Expensive Biotech Drugs

CVS Health is launching a new company that will work directly with drug makers to produce and commercialize “biosimilar” drugs, the less expensive versions of expensive brand prescriptions derived from biotechnology. The new of the new company, Cordavis, will operate as “a wholly owned subsidiary…#cvshealth #cordavis #cvs #fda #humira

Source: Reuters: Health - August 23, 2023 Category: Consumer Health News Source Type: news